Literature DB >> 2416113

Biochemical characterization of two Epstein-Barr virus early antigen-associated phosphopolypeptides.

D Roeckel, N Mueller-Lantzsch.   

Abstract

Epstein-Barr virus (EBV) nonproducer cells NC37 induced to viral early antigen (EA) synthesis by the tumor promotor 12-O-tetradecanoylphorbol-13-acetate (TPA) were labeled at Day 4 after induction with 32P, and were analyzed by immunoprecipitation with human EA-positive sera. By employing this method the appearance of two phosphopolypeptides of 50 and 58K (pp50 and pp58) was well correlated with EA complex. Partial V8 protease digestion and two-dimensional peptide analysis revealed that the polypeptides pp50 and pp58 are related. The analysis of phosphoamino acids indicated that pp58 contains phosphoserine and phosphothreonine to the same percentage, whereas in pp50 only phosphoserine was found. The analysis of the subcellular distribution revealed that pp50 and pp58 are located in the chromatin. Both phosphopolypeptides exhibit DNA-binding activity, and are recognized by two monoclonal antibodies described recently (R3 and 1108-1).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416113     DOI: 10.1016/0042-6822(85)90128-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.

Authors:  F A Grässer; P Haiss; S Göttel; N Mueller-Lantzsch
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Expression of an early Epstein-Barr virus antigen (EA-D) in E. coli. Brief report.

Authors:  D Roeckel; H Boos; N Mueller-Lantzsch
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs.

Authors:  A J Pfitzner; J L Strominger; S H Speck
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  Purification and characterization of the DNA-binding activity of the Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system.

Authors:  T Tsurumi
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Bipartite DNA-binding region of the Epstein-Barr virus BMRF1 product essential for DNA polymerase accessory function.

Authors:  A Kiehl; D I Dorsky
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains.

Authors:  S R Chan; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44.

Authors:  Laurie A Silva; Blair L Strang; Eric W Lin; Jeremy P Kamil; Donald M Coen
Journal:  Virology       Date:  2011-07-23       Impact factor: 3.616

10.  Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.